APROGEN INC.
10Patents
8Active
10Granted
49Portfolio score
Filing activity: Mar 22, 2003 → Sep 30, 2021 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7691366B2 | Chimeric CMP-Ang1 molecule | Chemistry; Metallurgy | 4 | Active |
| US8420353B2 | Humanized antibody and process for preparing same | Chemistry; Metallurgy | 2 | Expired |
| US8268316B2 | Monoclonal antibody specific to anthrax toxin | Chemistry; Metallurgy | 1 | Active |
| US8426570B2 | Recombinant expression vector for animal cell | Chemistry; Metallurgy | 0 | Active |
| US8414877B2 | Method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule | Chemistry; Metallurgy | 0 | Active |
| US8206698B2 | Method of treating a cutaneous wound using a coiled coil chimeric molecule | Chemistry; Metallurgy | 0 | Active |
| US10259860B2 | Fusion proteins binding to VEGF and angiopoietin | Chemistry; Metallurgy | 0 | Active |
| US11542339B2 | Anti-CD43 antibody and use thereof for cancer treatment | Physics | 0 | Active |
| US11820831B2 | Antibody binding to carbonic anhydrase and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US7691365B2 | Methods of using chimeric coiled coil molecule to treat ischemic disease | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.